全文获取类型
收费全文 | 232862篇 |
免费 | 20724篇 |
国内免费 | 8147篇 |
专业分类
耳鼻咽喉 | 1345篇 |
儿科学 | 3859篇 |
妇产科学 | 1886篇 |
基础医学 | 28778篇 |
口腔科学 | 3551篇 |
临床医学 | 22062篇 |
内科学 | 30565篇 |
皮肤病学 | 2698篇 |
神经病学 | 11890篇 |
特种医学 | 4435篇 |
外国民族医学 | 28篇 |
外科学 | 15943篇 |
综合类 | 33123篇 |
现状与发展 | 19篇 |
一般理论 | 30篇 |
预防医学 | 16177篇 |
眼科学 | 4681篇 |
药学 | 49675篇 |
51篇 | |
中国医学 | 12962篇 |
肿瘤学 | 17975篇 |
出版年
2024年 | 692篇 |
2023年 | 3295篇 |
2022年 | 6388篇 |
2021年 | 8643篇 |
2020年 | 7844篇 |
2019年 | 7720篇 |
2018年 | 7793篇 |
2017年 | 7865篇 |
2016年 | 7898篇 |
2015年 | 8030篇 |
2014年 | 12726篇 |
2013年 | 16785篇 |
2012年 | 12206篇 |
2011年 | 13410篇 |
2010年 | 11396篇 |
2009年 | 10855篇 |
2008年 | 10813篇 |
2007年 | 11788篇 |
2006年 | 10715篇 |
2005年 | 10385篇 |
2004年 | 9037篇 |
2003年 | 8087篇 |
2002年 | 6184篇 |
2001年 | 6027篇 |
2000年 | 4913篇 |
1999年 | 4495篇 |
1998年 | 3369篇 |
1997年 | 3067篇 |
1996年 | 3108篇 |
1995年 | 2930篇 |
1994年 | 2647篇 |
1993年 | 2316篇 |
1992年 | 2121篇 |
1991年 | 1839篇 |
1990年 | 1592篇 |
1989年 | 1453篇 |
1988年 | 1390篇 |
1987年 | 1183篇 |
1986年 | 911篇 |
1985年 | 1081篇 |
1984年 | 1094篇 |
1983年 | 700篇 |
1982年 | 809篇 |
1981年 | 709篇 |
1980年 | 601篇 |
1979年 | 518篇 |
1978年 | 446篇 |
1977年 | 371篇 |
1976年 | 406篇 |
1975年 | 281篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Objective
The aim of the study was to estimate the effect of the state-based reinsurance programs through the section 1332 State Innovation Waivers on health insurance marketplace premiums and insurer participation.Data Source
2015 to 2022 Robert Wood Johnson Foundation Health Insurance Exchange Compare Datasets.Study Design
An event study difference-in-differences (DD) model separately for each year of implementation and a synthetic control method (SCM) are used to estimate year-by-year effects following program implementation.Data Collection/Extraction Methods
Not applicable.Principal Findings
Reinsurance programs were associated with a decline in premiums in the first year of implementation by 10%–13%, 5%–19%, and 11%–17% for bronze, silver, and gold plans (p < 0.05). There is a trend of sustained declines especially for states that implemented their programs in 2019 and 2020. The SCM analyses suggest some effect heterogeneity across states but also premium declines across most states. There is no evidence that reinsurance programs affected insurer participation.Conclusion
State-based reinsurance programs have the potential to improve the affordability of health insurance coverage. However, reinsurance programs do not appear to have had an effect on insurer participation, highlighting the need for policy makers to consider complementary strategies to encourage insurer participation. 相似文献2.
3.
4.
徐华 《世界科学技术-中医药现代化》2022,24(5):338-348
目的 采用液质联用技术分析白鲜皮中的主要化学成分;基于网络药理学技术研究白鲜皮治疗皮肤湿疹的活性成分、作用靶点及作用机制。方法 利用液质联用技术(LC-MS)对白鲜皮主要成分进行分析,通过质谱数据结合文献资料,对各主要成分进行快速识别;通过利用SwissADME数据库对白鲜皮潜在活性成分进行预测,筛选主要作用靶点。进行KEGG通路富集分析,最终得到白鲜皮成分-靶点-疾病-通路网络图。采用分子对接技术对主要成分和作用靶点进行验证。结果 从白鲜皮中共分析鉴定了12种成分,进一步筛选得到4种潜在活性成分,可作用于48个关键靶点和14条主要通路。结论 采用LC-MS技术结合网络药理学方法,可以快速分析白鲜皮的潜在活性成分,并初步揭示了成分-靶点-通路之间的关系。通过分子对接技术可以做作用靶点进行验证。 相似文献
5.
6.
7.
8.
目的 基于文本挖掘技术和生物医学数据库对新型冠状病毒肺炎(COVID-19)相关文献进行数据挖掘分析,探究COVID-19及其主要症状发热、咳嗽、呼吸障碍相关基因靶点,筛选潜在有效的化学药和中药。方法 使用GenCLiP 3网站获取COVID-19和其主要症状咳嗽、发热、呼吸障碍共4个关键词的共有靶点,在METASCAPE数据库中对其进行基因本体(GO)和通路富集分析,再利用String数据库和Cytoscape软件构建共有靶点的蛋白质相互作用网络,筛选获得核心基因,运用DGIdb数据库、SymMap数据库针对核心基因进行中西医治疗药物预测。结果 获得COVID-19及其主要症状共有基因靶点28个,其中有IL2、IL1B、CCL2等核心基因16个,使用DGIdb数据库筛选获得与16个关键靶点相互作用的化学药包括沙利度胺、来氟米特、环孢素等28种,中药包括虎杖、黄芪、芦荟等70味。结论 COVID-19及其主要症状的病理机制可能和CD4、KNG1、VEGFA等28个共有基因相关,可能通过介导TNF、IL-17等信号通路参与COVID-19病理过程。潜在有效药物可能通过作用相关靶点通路起到治疗COVID-19的作用。 相似文献
9.
Kevin Kyung Ho Choi Santosh Sanagapalli 《World journal of gastrointestinal oncology》2022,14(3):568-586
Barrett's esophagus (BE) is the precursor to esophageal adenocarcinoma (EAC). Progression to cancer typically occurs in a stepwise fashion through worsening dysplasia and ultimately, invasive neoplasia. Established EAC with deep involvement of the esophageal wall and/or metastatic disease is invariably associated with poor long-term survival rates. This guides the rationale of surveillance of Barrett’s in an attempt to treat lesions at an earlier, and potentially curative stage. The last two decades have seen a paradigm shift in management of Barrett’s with rapid expansion in the role of endoscopic eradication therapy (EET) for management of dysplastic and early neoplastic BE, and there have been substantial changes to international consensus guidelines for management of early BE based on evolving evidence. This review aims to assist the physician in the therapeutic decision-making process with patients by comprehensive review and summary of literature surrounding natural history of Barrett’s by histological stage, and the effectiveness of interventions in attenuating the risk posed by its natural history. Key findings were as follows. Non-dysplastic Barrett’s is associated with extremely low risk of progression, and interventions cannot be justified. The annual risk of cancer progression in low grade dysplasia is between 1%-3%; EET can be offered though evidence for its benefit remains confined to highly select settings. High-grade dysplasia progresses to cancer in 5%-10% per year; EET is similarly effective to and less morbid than surgery and should be routinely performed for this indication. Risk of nodal metastases in intramucosal cancer is 2%-4%, which is comparable to operative mortality rate, so EET is usually preferred. Submucosal cancer is associated with nodal metastases in 14%-41% hence surgery remains standard of care, except for select situations. 相似文献
10.
Weina Cheng Yazhi Wang Jingxian Liu Xiaofei Li Ming Yu Cancan Duan Liu Liu Jianyong Zhang 《Journal of applied toxicology : JAT》2022,42(6):970-980
Cantharidin (CTD) is an effective antitumor agent. However, it exhibits significant hepatotoxicity, the mechanism of which remains unclear. In this study, biochemical and histopathological analyses complemented with ultra-high-performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS)-based targeted metabolomic analysis of bile acids (BAs) were employed to investigate CTD-induced hepatotoxicity in rats. Sixteen male and female Sprague–Dawley rats were randomly divided into two groups: control and CTD (1.0 mg/kg) groups. Serum and liver samples were collected after 28 days of intervention. Biochemical, histopathological, and BA metabolomic analyses were performed for all samples. Further, the key biomarkers of CTD-induced hepatotoxicity were identified via multivariate and metabolic pathway analyses. In addition, metabolite–gene–enzyme network and Kyoto Encyclopedia of Genes and Genomes pathway analyses were used to identify the signaling pathways related to CTD-induced hepatotoxicity. The results revealed significantly increased levels of biochemical indices (alanine aminotransferase, aspartate aminotransferase, and total bile acid). Histopathological analysis revealed that the hepatocytes were damaged. Further, 20 endogenous BAs were quantitated via UHPLC-MS/MS, and multivariate and metabolic pathway analyses of BAs revealed that hyocholic acid, cholic acid, and chenodeoxycholic acid were the key biomarkers of CTD-induced hepatotoxicity. Meanwhile, primary and secondary BA biosynthesis and taurine and hypotaurine metabolism were found to be associated with the mechanism by which CTD induced hepatotoxicity in rats. This study provides useful insights for research on the mechanism of CTD-induced hepatotoxicity. 相似文献